Medical - Devices
Compare Stocks
5 / 10Stock Comparison
VMD vs ADUS vs HCSG vs OPCH vs PNTG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
VMD vs ADUS vs HCSG vs OPCH vs PNTG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Devices | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $353M | $1.81B | $1.60B | $3.25B | $1.24B |
| Revenue (TTM) | $287M | $1.45B | $1.84B | $5.67B | $1.02B |
| Net Income (TTM) | $15M | $100M | $59M | $206M | $30M |
| Gross Margin | 57.5% | 32.5% | 13.3% | 18.0% | 11.1% |
| Operating Margin | 8.2% | 9.8% | 3.0% | 5.9% | 5.6% |
| Forward P/E | 19.2x | 14.1x | 20.8x | 11.1x | 27.0x |
| Total Debt | $16M | $209M | $25M | $0.00 | $453M |
| Cash & Equiv. | $14M | $82M | $161M | $233M | $17M |
VMD vs ADUS vs HCSG vs OPCH vs PNTG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Viemed Healthcare, … (VMD) | 100 | 110.6 | +10.6% |
| Addus HomeCare Corp… (ADUS) | 100 | 98.3 | -1.7% |
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| Option Care Health,… (OPCH) | 100 | 136.5 | +36.5% |
| The Pennant Group, … (PNTG) | 100 | 140.2 | +40.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VMD vs ADUS vs HCSG vs OPCH vs PNTG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VMD is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 413.5% 10Y total return vs ADUS's 399.9%
- 7.5% ROA vs PNTG's 3.5%, ROIC 11.6% vs 5.6%
ADUS has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.
- Dividend streak 2 yrs, beta 0.58
- Lower volatility, beta 0.58, Low D/E 19.2%, current ratio 1.80x
- PEG 0.70 vs PNTG's 2.68
- Lower P/E (14.1x vs 27.0x), PEG 0.70 vs 2.68
HCSG ranks third and is worth considering specifically for momentum.
- +55.8% vs OPCH's -37.9%
OPCH is the clearest fit if your priority is defensive.
- Beta 0.48, current ratio 1.53x
- Beta 0.48 vs HCSG's 1.12
PNTG is the clearest fit if your priority is growth exposure.
- Rev growth 36.3%, EPS growth 18.3%, 3Y rev CAGR 26.0%
- 36.3% revenue growth vs HCSG's 7.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.3% revenue growth vs HCSG's 7.1% | |
| Value | Lower P/E (14.1x vs 27.0x), PEG 0.70 vs 2.68 | |
| Quality / Margins | 6.9% margin vs PNTG's 3.0% | |
| Stability / Safety | Beta 0.48 vs HCSG's 1.12 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +55.8% vs OPCH's -37.9% | |
| Efficiency (ROA) | 7.5% ROA vs PNTG's 3.5%, ROIC 11.6% vs 5.6% |
VMD vs ADUS vs HCSG vs OPCH vs PNTG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VMD vs ADUS vs HCSG vs OPCH vs PNTG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OPCH leads in 2 of 6 categories
ADUS leads 1 • HCSG leads 1 • VMD leads 0 • PNTG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ADUS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OPCH is the larger business by revenue, generating $5.7B annually — 19.8x VMD's $287M. Profitability is closely matched — net margins range from 6.9% (ADUS) to 3.0% (PNTG). On growth, PNTG holds the edge at +36.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $287M | $1.4B | $1.8B | $5.7B | $1.0B |
| EBITDAEarnings before interest/tax | $46M | $159M | $72M | $406M | $66M |
| Net IncomeAfter-tax profit | $15M | $100M | $59M | $206M | $30M |
| Free Cash FlowCash after capex | $26M | $137M | $139M | $244M | $47M |
| Gross MarginGross profit ÷ Revenue | +57.5% | +32.5% | +13.3% | +18.0% | +11.1% |
| Operating MarginEBIT ÷ Revenue | +8.2% | +9.8% | +3.0% | +5.9% | +5.6% |
| Net MarginNet income ÷ Revenue | +5.2% | +6.9% | +3.2% | +3.6% | +3.0% |
| FCF MarginFCF ÷ Revenue | +9.0% | +9.5% | +7.6% | +4.3% | +4.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.5% | +7.7% | +6.6% | +1.3% | +36.0% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | +17.2% | +175.0% | +3.6% | +9.1% |
Valuation Metrics
OPCH leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 16.3x trailing earnings, OPCH trades at a 62% valuation discount to PNTG's 42.5x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.93x vs PNTG's 4.23x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $353M | $1.8B | $1.6B | $3.2B | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $356M | $1.9B | $1.5B | $3.0B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | 24.89x | 18.67x | 27.54x | 16.34x | 42.54x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.19x | 14.12x | 20.83x | 11.12x | 26.97x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.93x | — | — | 4.23x |
| EV / EBITDAEnterprise value multiple | 7.21x | 12.52x | 22.38x | 7.38x | 27.97x |
| Price / SalesMarket cap ÷ Revenue | 1.31x | 1.28x | 0.87x | 0.57x | 1.31x |
| Price / BookPrice ÷ Book value/share | 2.62x | 1.65x | 3.19x | 2.56x | 3.37x |
| Price / FCFMarket cap ÷ FCF | 29.59x | 17.48x | 11.49x | 12.56x | 47.16x |
Profitability & Efficiency
OPCH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
OPCH delivers a 15.3% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $8 for PNTG. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to PNTG's 1.21x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs PNTG's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.5% | +9.3% | +11.8% | +15.3% | +8.4% |
| ROA (TTM)Return on assets | +7.5% | +7.0% | +7.3% | +6.0% | +3.5% |
| ROICReturn on invested capital | +11.6% | +8.8% | +9.0% | +15.3% | +5.6% |
| ROCEReturn on capital employed | +13.2% | +10.9% | +7.7% | +12.8% | +7.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 7 | 5 | 3 |
| Debt / EquityFinancial leverage | 0.11x | 0.19x | 0.05x | — | 1.21x |
| Net DebtTotal debt minus cash | $2M | $127M | -$136M | -$233M | $436M |
| Cash & Equiv.Liquid assets | $14M | $82M | $161M | $233M | $17M |
| Total DebtShort + long-term debt | $16M | $209M | $25M | $0 | $453M |
| Interest CoverageEBIT ÷ Interest expense | 14.61x | 14.45x | 33.02x | 5.50x | 16.52x |
Total Returns (Dividends Reinvested)
Evenly matched — HCSG and PNTG each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OPCH five years ago would be worth $11,803 today (with dividends reinvested), compared to $7,888 for HCSG. Over the past 12 months, HCSG leads with a +55.8% total return vs OPCH's -37.9%. The 3-year compound annual growth rate (CAGR) favors PNTG at 44.9% vs OPCH's -9.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +27.6% | -8.7% | +28.6% | -35.6% | +28.4% |
| 1-Year ReturnPast 12 months | +26.7% | -13.4% | +55.8% | -37.9% | +28.7% |
| 3-Year ReturnCumulative with dividends | -14.6% | +16.3% | +48.6% | -26.3% | +204.1% |
| 5-Year ReturnCumulative with dividends | -3.8% | +0.0% | -21.1% | +18.0% | -6.9% |
| 10-Year ReturnCumulative with dividends | +413.5% | +399.9% | -26.8% | +97.2% | +136.8% |
| CAGR (3Y)Annualised 3-year return | -5.1% | +5.2% | +14.1% | -9.7% | +44.9% |
Risk & Volatility
Evenly matched — OPCH and PNTG each lead in 1 of 2 comparable metrics.
Risk & Volatility
OPCH is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PNTG currently trades 99.7% from its 52-week high vs OPCH's 56.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 0.58x | 1.12x | 0.48x | 0.79x |
| 52-Week HighHighest price in past year | $10.18 | $124.44 | $24.39 | $36.80 | $35.84 |
| 52-Week LowLowest price in past year | $5.93 | $90.89 | $12.66 | $18.01 | $21.73 |
| % of 52W HighCurrent price vs 52-week peak | +90.5% | +78.2% | +91.5% | +56.4% | +99.7% |
| RSI (14)Momentum oscillator 0–100 | 34.7 | 49.3 | 61.8 | 22.5 | 62.5 |
| Avg Volume (50D)Average daily shares traded | 312K | 236K | 676K | 2.4M | 245K |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: VMD as "Buy", ADUS as "Buy", HCSG as "Hold", OPCH as "Buy", PNTG as "Buy". Consensus price targets imply 59.0% upside for OPCH (target: $33) vs 9.2% for PNTG (target: $39).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $128.67 | $24.50 | $33.00 | $39.00 |
| # AnalystsCovering analysts | 1 | 15 | 15 | 14 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 2 | 2 | 20 | 1 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.7% | 0.0% | +3.9% | +9.5% | 0.0% |
OPCH leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). ADUS leads in 1 (Income & Cash Flow). 2 tied.
VMD vs ADUS vs HCSG vs OPCH vs PNTG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VMD or ADUS or HCSG or OPCH or PNTG a better buy right now?
For growth investors, The Pennant Group, Inc.
(PNTG) is the stronger pick with 36. 3% revenue growth year-over-year, versus 7. 1% for Healthcare Services Group, Inc. (HCSG). Option Care Health, Inc. (OPCH) offers the better valuation at 16. 3x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Viemed Healthcare, Inc. (VMD) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VMD or ADUS or HCSG or OPCH or PNTG?
On trailing P/E, Option Care Health, Inc.
(OPCH) is the cheapest at 16. 3x versus The Pennant Group, Inc. at 42. 5x. On forward P/E, Option Care Health, Inc. is actually cheaper at 11. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus The Pennant Group, Inc. 's 2. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VMD or ADUS or HCSG or OPCH or PNTG?
Over the past 5 years, Option Care Health, Inc.
(OPCH) delivered a total return of +18. 0%, compared to -21. 1% for Healthcare Services Group, Inc. (HCSG). Over 10 years, the gap is even starker: VMD returned +413. 5% versus HCSG's -26. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VMD or ADUS or HCSG or OPCH or PNTG?
By beta (market sensitivity over 5 years), Option Care Health, Inc.
(OPCH) is the lower-risk stock at 0. 48β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately 136% more volatile than OPCH relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 121% for The Pennant Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VMD or ADUS or HCSG or OPCH or PNTG?
By revenue growth (latest reported year), The Pennant Group, Inc.
(PNTG) is pulling ahead at 36. 3% versus 7. 1% for Healthcare Services Group, Inc. (HCSG). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to 3. 3% for Option Care Health, Inc.. Over a 3-year CAGR, PNTG leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VMD or ADUS or HCSG or OPCH or PNTG?
Addus HomeCare Corporation (ADUS) is the more profitable company, earning 6.
7% net margin versus 3. 1% for The Pennant Group, Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus 2. 6% for HCSG. At the gross margin level — before operating expenses — VMD leads at 57. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VMD or ADUS or HCSG or OPCH or PNTG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus The Pennant Group, Inc. 's 2. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Option Care Health, Inc. (OPCH) trades at 11. 1x forward P/E versus 27. 0x for The Pennant Group, Inc. — 15. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPCH: 59. 0% to $33. 00.
08Which pays a better dividend — VMD or ADUS or HCSG or OPCH or PNTG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is VMD or ADUS or HCSG or OPCH or PNTG better for a retirement portfolio?
For long-horizon retirement investors, Addus HomeCare Corporation (ADUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
58), +399. 9% 10Y return). Both have compounded well over 10 years (ADUS: +399. 9%, HCSG: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VMD and ADUS and HCSG and OPCH and PNTG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VMD is a small-cap high-growth stock; ADUS is a small-cap high-growth stock; HCSG is a small-cap quality compounder stock; OPCH is a small-cap deep-value stock; PNTG is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.